ENERGY CO OF PARANA (ELPC): what the price requires
At today's price, ENERGY CO OF PARANA (ELPC) is priced for today's economics sustained for ~10.7 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-19 · Exported: 2026-07-20 · Source: https://boothcheck.com/report/ELPC
Headline
| Field | Value |
|---|---|
| Ticker | ELPC |
| Company | ENERGY CO OF PARANA |
| Sector / Industry | Utilities |
| Current price | $11.54/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | revenue-multiple |
| EV / sales paid | 7.5x |
| Steady-state operating margin assumed | 8.6% |
| Must persist for | 10.7y |
The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.
Solve inputs: computed at a 7.9% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.4 years.
Reconcile: at the x-ray's 9.3% required return this reads ~14 years; the models below use their own rates.
How unusual the bet is: high
| Reference | Value |
|---|---|
| vs own history | +3.51σ |
| sustained it ~10 years at this level | 14% |
| implied end-window share | 0% |
Valuation X-Ray
Every valuation family lands below the price. The price therefore requires assumptions beyond what those standard frames encode.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 4.91x | 3 | expensive |
| Earnings | 3.94x | 1 | expensive |
| Relative | 2.84x | 2 | expensive |
| Growth | 1.77x | 2 | expensive |
Families that call it expensive: Asset, Earnings, Relative, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.3%); the inversion above states its own rate.
Per-Model Detail (n=8)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $5.16 | 2.24x | yes | FCF base $0.7B, growth 5% (input: historical growth), terminal g 4.0%, WACC 9.3%, 6yr projection |
| DCF Exit Multiple | Growth | $0.00 | — | no | Negative/zero FCF or EBITDA — equity value floored at $0 |
| Relative Valuation | Relative | $4.06 | 2.84x | yes | P/S fallback (negative EPS): Sector P/S 2.5x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $2.17 | 5.32x | yes | BV/sh $1.84, ROE (TTM) 10.9%, ke 9.3% |
| Two-Stage Excess Return | Asset | $2.35 | 4.91x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $8.84 | 1.31x | yes | Rev $4.4B, growth 5% (input: historical growth; tapered), Terminal P/S: 5.9x / 7.1x / 8.3x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | $2.38 | 4.85x | yes | BV $1.84 + 5yr PV of (ROE (TTM) 10.9% − Kₑ 9.3%) × BV; BV grows 7.1%/yr |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | $2.93 | 3.94x | yes | FCF $665.4M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $4.06 | 2.84x | yes | Revenue $4.44B × sector P/S 2.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net cash | $804.6m |
| Interest coverage | -0.4x |
| Burning cash | no |
Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.
Bullet Takeaways
- Copel is a recently privatized Paraná electric utility: since its 2023 privatization it has had no controlling shareholder and now commits to a minimum 75% profit payout, with over R$3.1 billion in dividends and interest on equity committed across 2026.
- The clearest risk is regulated returns meeting a stretched balance sheet: net debt sat near R$17.5 billion, about 2.8 times recurring EBITDA at a 13.05% average nominal cost, and the board just extended its deleveraging window to 48 months.
- Watch the June 2026 tariff reset, an average 20.51% increase across roughly 5.3 million Paraná consumer units, flow into distribution revenue over coming quarters, alongside service-quality metrics that ranked the utility among Brazil's worst three large distributors in 2024.
Bull Case
Start with what the standard methods say, because the bull case has to answer it. At $11.54, the price sits above every conventional valuation family, from asset value through earnings power and peer multiples to forward growth, and even the most generous of them, the forward-growth methods, reaches only about 1.8 times below today's price. On the trailing numbers, nothing gets you to $11.54. The bull's claim is that the trailing numbers are the wrong anchor for a company reshaped by its 2023 privatization.
The substance behind the premium is a governance change, not a growth fantasy. When Copel privatized in 2023 it became a corporation with no controlling shareholder, the first among Brazil's large state electric utilities to take that structure, which handed management a mandate to cut costs and optimize assets that a state-controlled board never carried. The early operating numbers show it moving: first-quarter 2026 net operating revenue rose 20% to R$7.07 billion, recurring EBITDA rose 16.7% to R$1.75 billion, and recurring net income grew 10.7%. A thin reported book value understates a business throwing off that much cash.
For an income-oriented holder the mechanism is simple. Copel now commits to distributing at least 75% of net profit, roughly tripling the dividend floor it carried as a state company, and in 2025 it actually paid out 144.4% of profit. The regulated tariff base grows on a schedule the economy cannot vote down: ANEEL's June 2026 review lifted average tariffs 20.51% across roughly 5.3 million consumer units, a revenue increase the distributor collects mechanically. The forward-growth lens reaching closest to the price is not an accident. It is the one frame that credits the earnings normalization the privatization set in motion, and that normalization is the bet a buyer at $11.54 is making.
Bear Case
A regulated distributor does not get disrupted by a competitor. It gets disrupted by its regulator and by its own service quality, and Copel is exposed on both. After four straight years of decline, Copel's distribution arm ended 2024 ranked 29th of 31 large Brazilian distributors, among the three worst in the country. In Brazil's concession model that is not cosmetic: distribution concessions are renewed against quality and investment targets, and ANEEL can attach conditions or penalties when a concessionaire slips. The June 2026 tariff increase helps revenue, but a 20.51% bill increase landing on 5.3 million consumers in a single state invites political and regulatory scrutiny that a company with a poor service record is badly placed to absorb.
Underneath the regulatory risk sits a valuation the fundamentals do not comfortably support. Inverted, today's price assumes the business reaches an operating margin near 8.6% and holds it, growing revenue at its self-funding pace, for about 10.9 years. For a distributor whose allowed returns are set by the regulator rather than the market, more than a decade of sustained above-trend performance is a demanding thing to underwrite, and history says only a minority of companies that start down that path stay on it. If the normalization arrives slower than the price assumes, the premium the price carries over asset value and earnings power has a long way to fall.
The balance sheet turns the dividend promise into a tension rather than a comfort. Net debt stood near R$17.5 billion at the end of March 2026, about 2.8 times recurring EBITDA, financed at an average nominal cost of 13.05% in an economy where high base rates make that expensive to carry. Committing to pay out at least three-quarters of profit while carrying that leverage is precisely why the board just doubled its leverage-normalization window to 48 months. For a dollar-based holder there is one more layer: revenue, costs, and dividends are all in reais, so the Brazilian currency sits between Copel's operations and the return an ELPC shareholder actually banks. The regulator sets the ceiling on returns, and the currency and the debt cost set the floor under the risk.
Valuation
At $11.54 (July 19, 2026), Copel does something a regulated utility rarely does: it trades above every standard way of valuing it. The price sits nearly five times the asset-value methods, about 3.9 times the earnings-power methods, about 2.8 times peer multiples, and about 1.8 times even the forward-growth methods, the most generous frame of the four. On the trailing numbers, no ordinary valuation lens reaches $11.54. That spread is the valuation question in one line.
What the gap is paying for is a normalization the trailing statement does not yet show. Inverted, the price assumes the business eventually earns an operating margin near 8.6% and grows revenue at its self-funding pace for about 10.9 years, set against a trailing operating line that currently reads negative in the standardized accounts. This is a low-confidence read, so treat the point as directional rather than precise. The tell is that the trailing operating figure and the cash the company actually distributes disagree sharply: Copel committed over R$3.1 billion in dividends and interest on equity across 2026 and carried a 144.4% payout on 2025 profit. A business genuinely depressed at the operating line does not fund that. The forward-growth methods reaching closest to the price are the honest read: the market is paying for post-privatization earnings power the backward-looking methods structurally miss.
On the balance sheet the picture is the opposite of comfortable, and it is where the downside lives. Net debt stood at R$17.5 billion at the end of March 2026, about 2.8 times recurring EBITDA, at an average nominal cost of 13.05%. In July 2026 the board stretched the window to return leverage to target from 24 to 48 months while holding the 75% minimum payout. Paying out three-quarters of profit while deleveraging over four years is a choice the price is underwriting as much as any operating margin.
Catalysts
The near-term catalyst is already in the numbers but not yet fully in the run-rate. ANEEL's tariff review took effect June 24, 2026, lifting average tariffs 20.51% across Copel's roughly 5.3 million Paraná consumer units, and the revenue lift phases into results over the following quarters rather than all at once. The next quarterly print is where to watch whether distribution revenue steps up as the reset flows through.
Capital return is the other live thread. Across 2026 Copel has committed to over R$3.1 billion in dividends and interest on equity, including R$1.1 billion in interest on equity paid in January and R$1.35 billion in dividends scheduled. In July 2026 the board reaffirmed the minimum 75% payout while extending the leverage-normalization window to 48 months, a signal worth tracking because it shows how the company is balancing shareholder returns against a net-debt load near 2.8 times EBITDA.
The slower-moving item to watch is service quality. Copel's distribution ranking among the worst large concessionaires in Brazil is the metric most likely to attract regulatory conditions or investment mandates over the next several years, and improvement there is what would turn the tariff-base growth into a durable return rather than a one-time reset.
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Copel dividend policy update, Form 6-K, July 2026 · Copel Q1 2026 results, Form 6-K · ANEEL tariff revision and Gazeta do Paraná quality ranking, 2024 to 2026 · ANEEL tariff revision, June 2026 · Gazeta do Paraná quality ranking, 2024 · Copel investor releases, 2026